In 2017, a Miami–Berlin flight took an unexpected turn when passengers spotted a rat on board. After landing, the rat was captured and handed over to scientists at the Friedrich-Loeffler-Institut (FLI). There, it was not only seen as a nuisance, but also as an opportunity to examine it as a potential carrier of pathogens. Investigations by scientists from the German Center for Infection Research (DZIF), in collaboration with many other scientists from the “Rodent-borne pathogens network (NaÜPa-net)”, revealed only a few zoonotic and non-zoonotic pathogens. However, the incident underscored how easily pathogens can spread across continents—and why standardized testing of animal stowaways is so important. The findings were recently published in the journal Scientific Reports.

High-grade endometrial carcinoma (HGEC) is an aggressive tumor with increasing incidence and mortality. Traditional classifications, such as Bokhman’s dualistic model and the World Health Organization histopathological system, have limitations due to tumor heterogeneity and interobserver variability. This review provides a comprehensive understanding of how integrating histopathological and molecular data, particularly The Cancer Genome Atlas (TCGA) classification, advances risk stratification and personalized treatment in HGEC. It highlights current challenges and identifies future directions to improve diagnostic accuracy and patient outcomes through precision medicine.

New research in JNCCN validates the use of the “Geriatric Oncology Potentially Inappropriate Medications” (GO-PIMS) scale, from the NCCN Guidelines for Older Adult Oncology, to identify high-risk medications that impact patients and outcomes negatively.

The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases

Rice scientists have developed a new drug delivery platform that could make it easier for patients to take their medications and may even boost drug efficacy.

Renovated location will offer pioneering treatments and lead innovative research in rehabilitation medicine